Eterna Therapeutics
ERNA
#11171
Rank
HK$18.04 M
Marketcap
HK$10.66
Share price
-16.56%
Change (1 day)
1.47%
Change (1 year)

EPS for Eterna Therapeutics (ERNA)

EPS in 2026 (TTM): -HK$229.56

According to Eterna Therapeutics's latest financial reports the company's current EPS (TTM) is -HK$229.59. In 2022 the company made an earnings per share (EPS) of -HK$24,662 an increase over its 2021 EPS that were of -HK$162,935.

EPS history for Eterna Therapeutics from 2021 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$229.56
2022-HK$24,662-84.86%
2021-HK$162,935

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
HK$15.52-106.76%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
-HK$11.05-95.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Omeros Corporation
OMER
HK$13.40-105.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
-HK$0.63-99.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
N/AN/A๐Ÿ‡ฆ๐Ÿ‡บ Australia
Teva Pharmaceutical Industries
TEVA
HK$3.53-101.54%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Bio-Techne
TECH
HK$9.17-103.99%๐Ÿ‡บ๐Ÿ‡ธ USA